These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19023549)

  • 1. Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate).
    Durán N; Alvarenga MA; Da Silva EC; Melo PS; Marcato PD
    Arch Pharm Res; 2008 Nov; 31(11):1509-16. PubMed ID: 19023549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of sustained release rifampicin microparticles for inhalation.
    Son YJ; McConville JT
    J Pharm Pharmacol; 2012 Sep; 64(9):1291-302. PubMed ID: 22881441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application.
    Masood F; Chen P; Yasin T; Fatima N; Hasan F; Hameed A
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1054-60. PubMed ID: 23827542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of emulsification-diffusion parameters on the formation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) particles.
    Göz E; Karakeçili A
    Artif Cells Nanomed Biotechnol; 2016; 44(1):226-34. PubMed ID: 25058033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ethylene carbonate)-containing polylactic acid microparticles with rifampicin improve drug delivery to macrophages.
    Priemel PA; Wang Y; Bohr A; Water JJ; Yang M; Mørck Nielsen H
    J Pharm Pharmacol; 2018 Aug; 70(8):1009-1021. PubMed ID: 29851078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation.
    Rezaie Shirmard L; Bahari Javan N; Khoshayand MR; Kebriaee-Zadeh A; Dinarvand R; Dorkoosh FA
    Pharm Dev Technol; 2017 Nov; 22(7):860-870. PubMed ID: 26555615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties.
    Gangrade N; Price JC
    J Microencapsul; 1991; 8(2):185-202. PubMed ID: 1765899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(3-hydroxybutyrate-co-epsilon-caprolactone) copolymers and poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-epsilon-caprolactone) terpolymers as novel materials for colloidal drug delivery systems.
    Pignatello R; Musumeci T; Impallomeni G; Carnemolla GM; Puglisi G; Ballistreri A
    Eur J Pharm Sci; 2009 Jun; 37(3-4):451-62. PubMed ID: 19504659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin carrying polyhydroxybutyrate microspheres as a potential chemoembolization agent.
    Kassab AC; Xu K; Denkbaş EB; Dou Y; Zhao S; Pişkin E
    J Biomater Sci Polym Ed; 1997; 8(12):947-61. PubMed ID: 9399144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation.
    Bayrami S; Esmaili Z; SeyedAlinaghi S; Jamali Moghadam SR; Bayrami S; Akbari Javar H; Rafiee Tehrani M; Dorkoosh FA
    Pharm Dev Technol; 2019 Feb; 24(2):176-188. PubMed ID: 29557733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-3-hydroxybutyrate-co-3-hydroxyvalerate containing scaffolds and their integration with osteoblasts as a model for bone tissue engineering.
    Zhang S; Prabhakaran MP; Qin X; Ramakrishna S
    J Biomater Appl; 2015 May; 29(10):1394-406. PubMed ID: 25592285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(lactic-
    Maghrebi S; Joyce P; Jambhrunkar M; Thomas N; Prestidge CA
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):8030-8039. PubMed ID: 32013379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.
    Manca ML; Mourtas S; Dracopoulos V; Fadda AM; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):220-31. PubMed ID: 18023977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and evaluation of antibacterial properties of epirubicin loaded PHB and PHBV nanoparticles.
    Perveen K; Masood F; Hameed A
    Int J Biol Macromol; 2020 Feb; 144():259-266. PubMed ID: 31821825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
    Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K
    Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment.
    Lee MY; Bourgeois S; Almouazen E; Pelletier J; Renaud F; Fessi H; Kodjikian L
    Int J Pharm; 2016 May; 505(1-2):262-70. PubMed ID: 26997423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of organosoluble salts on the nanofibrous structure of electrospun poly(3-hydroxybutyrate-co-3-hydroxyvalerate).
    Choi JS; Lee SW; Jeong L; Bae SH; Min BC; Youk JH; Park WH
    Int J Biol Macromol; 2004 Aug; 34(4):249-56. PubMed ID: 15374681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic release from biodegradable PHBV microparticles.
    Sendil D; Gürsel I; Wise DL; Hasirci V
    J Control Release; 1999 May; 59(2):207-17. PubMed ID: 10332055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of rifampicin to tuberculosis-infected macrophages: design, in-vitro, and in-vivo performance of rifampicin-loaded poly(ester amide)s nanocarriers.
    Amarnath Praphakar R; Munusamy MA; Sadasivuni KK; Rajan M
    Int J Pharm; 2016 Nov; 513(1-2):628-635. PubMed ID: 27693734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.